Bayesian Capital Management, LP Innoviva, Inc. Transaction History
Bayesian Capital Management, LP
- $838 Million
- Q3 2024
A detailed history of Bayesian Capital Management, LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 14,500 shares of INVA stock, worth $266,945. This represents 0.03% of its overall portfolio holdings.
Number of Shares
14,500Holding current value
$266,945% of portfolio
0.03%Shares
7 transactions
Others Institutions Holding INVA
# of Institutions
226Shares Held
79.1MCall Options Held
37.6KPut Options Held
300-
Black Rock Inc. New York, NY9.63MShares$177 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$134 Million34.93% of portfolio
-
Franklin Resources Inc San Mateo, CA6.75MShares$124 Million0.04% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$115 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.23MShares$115 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.28B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...